English  |  正體中文  |  简体中文  |  2831143  
???header.visitor??? :  33124221    ???header.onlineuser??? :  925
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"monturus e"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-2 of 2  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
國家衛生研究院 2021-02-04 Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer in the APHINITY trial: 6 years' follow-up Piccart, M;Procter, M;Fumagalli, D;de Azambuja, E;Clark, E;Ewer, MS;Restuccia, E;Jerusalem, G;Dent, S;Reaby, L;Bonnefoi, H;Krop, I;Liu, TW;Pieńkowski, T;Toi, M;Wilcken, N;Andersson, M;Im, YH;Tseng, LM;Lueck, HJ;Colleoni, M;Monturus, E;Sicoe, M;Guillaume, S;Bines, J;Gelber, RD;Viale, G;Thomssen, C; the APHINITY Steering Committee and Investigators
國家衛生研究院 2020-02 Interim overall survival analysis of APHINITY (BIG 4-11): A randomized multicenter, double-blind, placebo-controlled trial comparing chemotherapy plus trastuzumab plus pertuzumab versus chemotherapy plus trastuzumab plus placebo as adjuvant therapy in pat Piccart, M;Procter, M;Fumagalli, D;de Azambuja, E;Clark, E;Ewer, MS;Restuccia, E;Jerusalem, G;Dent, S;Reaby, L;Bonnefoi, H;Krop, I;Liu, TW;Pienkowski, T;Toi, M;Wilcken, N;Andersson, M;Im, YH;Tseng, LM;Lueck, HJ;Colleoni, M;Monturus, E;Sicoe, M;Guillaume, S;Bines, J;Gelber, R;Viale, G;Thomssen, C

Showing items 1-2 of 2  (1 Page(s) Totally)
1 
View [10|25|50] records per page